[在异性造血干细胞移植后的移植前死亡率的原因和特征]
1Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematological Diseases, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematology, Beijing 100044, China.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
|August 12, 2024
概括
感染是所有原性造血干细胞移植 (allo-HSCT) 后早期死亡的主要原因. 对于接受allo-HSCT.的重症无形成性贫血 (SAA) 患者来说,心脏毒性是一个重大问题.
科学领域:
- 血液学 血液学 血液学
- 移植医学 移植医学
- 在瘤学瘤学.
背景情况:
- 全基血造干细胞移植 (allo-HSCT) 是各种血液恶性瘤和骨髓衰竭综合征的关键治疗方法.
- 移植前的死亡率仍然是一个重大挑战,影响了患者的治疗结果和移植后的生存率.
- 了解早期死亡的原因和风险因素对于改善alo-HSCT协议至关重要.
研究的目的:
- 分析接受alo-HSCT的患者移植前死亡率的原因和人口特征.
- 确定与移植前死亡率相关的风险因素.
- 调查潜在的预防措施,以预防移植前的死亡率.
主要方法:
- 对接受allo-HSCT.的7427名患者进行了回顾性病例分析.
- 2016年1月至2023年7月期间从北京大学人民医院收集的数据.
- 分析的重点是植入前死亡的原因,时间和相关条件.
主要成果:
- 总共有56名患者 (0.75%) 经历了移植前死亡.
- 感染 (39.3%),心脏毒性 (28.6%) 和内出血 (26.8%) 是主要原因.
- 感染在急性白血病和骨髓质疏松症候群患者中最高;心脏毒性在重症无形成性贫血患者中突出.
结论:
- 感染是所有HSCT患者移植前死亡的主要原因.
- 严重的心脏毒性对接受alo-HSCT的严重无细胞性贫血患者来说是一个关键问题,需要密切监测.
- 针对感染和心脏并发症的有针对性的干预措施对于降低移植前死亡率至关重要.
相关概念视频
Bone Marrow Sampling and Transplants
317
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
317
Tissue Transplantation
350
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
350
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


